Spero TherapeuticsSPRO
那斯達克 · USD
2.35
+0.02
(+0.86%)
收盤 12/12 04:55 (UTC+8)
12/12 04:55 (UTC+8)
Spero TherapeuticsSPRO
2.35
+0.02
(+0.86%)
財務數據
損益表
- 0.03
- 0.25
- 0.74
- 0.09
- 0.10
- 0.13
- 0.15
- 0.06
- 0.14
- 0.05
- 31.32
- 837.54
- 188.63
- -87.40
- 10.04
- 32.09
- 11.69
- -60.95
- 141.56
- -61.65
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 5,442 | 14,189 | 5,874 | 15,044 | 13,469 | 10,197 | 9,267 | 73,522 | 25,473 | 2,717 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 5,442 | 14,189 | 5,874 | 15,044 | 13,469 | 10,197 | 9,267 | 73,522 | 25,473 | 2,717 |
營業費用 | 13,358 | 16,633 | 20,605 | 36,769 | 32,062 | 29,258 | - | 22,990 | 27,408 | 15,606 |
研發費用 | 8,597 | 10,672 | 13,606 | 28,836 | 26,864 | 23,725 | 17,332 | 16,557 | 16,394 | 9,510 |
推銷及管理費用 | 4,174 | 5,878 | 6,824 | 7,056 | 5,198 | 5,533 | 5,917 | 6,433 | 5,708 | 6,096 |
非經常性項目費用 | 587 | 83 | 175 | 877 | - | - | - | - | 5,306 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,916 | -2,444 | -14,731 | -21,725 | -18,593 | -19,061 | -13,982 | 50,532 | -1,935 | -12,889 |
其他收入及費用 | 534 | 744 | 865 | 1,127 | 1,156 | 1,199 | 1,313 | 1,046 | 941 | 975 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -7,382 | -1,700 | -13,866 | -20,598 | -17,437 | -17,862 | -12,669 | 51,578 | -994 | -11,914 |
所得稅 | - | - | - | 290 | -290 | - | - | 387 | 2,211 | - |
稅後純益 | -7,382 | -1,700 | -13,866 | -20,888 | -17,147 | -17,862 | -12,669 | 51,191 | -3,205 | -11,914 |
基本每股稅後盈餘(元) | -0.13 | -0.03 | -0.25 | -0.38 | -0.32 | -0.33 | -0.24 | - | -0.06 | -0.23 |
稀釋每股稅後盈餘(元) | -0.13 | -0.03 | -0.25 | -0.38 | -0.32 | -0.33 | -0.24 | 0.97 | -0.06 | -0.23 |
基本平均股數(千股) | 56280.00 | 56026.00 | 55376.00 | 54538.00 | 54124.00 | 53957.00 | 53524.00 | - | 52710.00 | 52571.00 |
稀釋平均股數(千股) | 56280.00 | 56026.00 | 55376.00 | 54538.00 | 54124.00 | 53957.00 | 53524.00 | - | 52710.00 | 52571.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.03 | -0.25 | -0.38 | -0.32 | -0.33 | -0.24 | - | -0.06 | -0.23 |
還原稀釋每股稅後盈餘(元) | -0.13 | -0.03 | -0.25 | -0.38 | -0.32 | -0.33 | -0.24 | 0.97 | -0.06 | -0.23 |
還原基本平均股數(千股) | 56,280 | 56,026 | 55,376 | 54,538 | 54,124 | 53,957 | 53,524 | - | 52,710 | 52,571 |
還原稀釋平均股數(千股) | 56,280 | 56,026 | 55,376 | 54,538 | 54,124 | 53,957 | 53,524 | - | 52,710 | 52,571 |
EBITDA(千元) | -7,382 | -1,700 | -13,866 | -20,598 | -17,437 | -17,860 | -12,669 | 51,616 | -886 | -11,806 |